In vivo and in vitro effects of Nocardia rubra cell wall skeleton on natural killer activity in mice. 1983

N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi

The in vivo and in vitro effects of Nocardia rubra cell wall skeleton (N-CWS) on natural killer (NK) activity of spleen and peritoneal lymphocytes of C57BL/6 mice were studied. The NK activity of spleen and peritoneal lymphocytes against YAC-1 lymphoma cells and cultured B-16 melanoma cells peaked at 3 days after intraperitoneal or intravenous administration of N-CWS, and returned to the normal value 7 days later. The NK activity of spleen lymphocytes was augmented by in vitro incubation with N-CWS. The appropriate concentration of N-CWS for the in vitro stimulation of NK activity in spleen lymphocytes was 2-5 micrograms/ml.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009615 Nocardia A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals. Micropolyspora
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
October 1978, Gan,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
January 2022, Pathology oncology research : POR,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
April 1986, Cancer research,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
November 1989, Japanese journal of cancer research : Gann,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
January 1988, Cancer immunology, immunotherapy : CII,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
October 1986, Arzneimittel-Forschung,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
June 1982, Gan,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
January 1992, Cancer immunology, immunotherapy : CII,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
January 1981, Cancer treatment reports,
N Saijo, and A Ozaki, and Y Beppu, and N Irimajiri, and M Shibuya, and E Shimizu, and T Takizawa, and T Taniguchi, and A Hoshi
October 1991, Cancer research,
Copied contents to your clipboard!